George Solomon
Clinical trials sponsored by George Solomon, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Personalized drug trial offers hope for cystic fibrosis patients with rare gene mutations Results expected Jan 2027 (estimated)
-
Personalized drug trial offers hope for cystic fibrosis patients with rare gene mutations
Disease control Recruiting nowThis early-phase trial is testing whether certain cystic fibrosis drugs, called CFTR modulators, can help people with rare gene mutations that are not currently approved for these medications. The study will enroll 20 participants aged 6 and older and measure changes in lung func…
Early phase 1 • Sponsor: George Solomon • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Rare CF mutation study aims to unlock new treatments
Knowledge-focused Recruiting nowThis study collects blood, nasal, and intestinal cells from 500 people with cystic fibrosis caused by rare mutations. The cells are stored in a bank and shared with researchers to test potential new drugs in the lab. It is a first step toward finding treatments for those who cann…
Sponsor: George Solomon • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC